Spiriva Generic Must Deliver To Maintain Exit Margin Estimates At Lupin
Q1 Results Reflect Return To Form After Muted Performance
The performance of its recently-launched Spiriva generic will be crucial for Lupin’s future performance, as it forecasts year-end exit margins in the high teens.
